MKL1/miR34a/FOXP3 axis regulates cell proliferation in gastric cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Megakaryoblastic leukemia 1 (MKL1) is implicated in various cancers.
• MicroRNA 34a (miR34a) is linked to cancer cell proliferation.
• Forkhead box protein 3 (FOXP3) has context-dependent roles in cancer.
• Cyclin-dependent kinase 6 (CDK6) regulates cell cycle progression and is often upregulated in cancers.

Purpose of the Study:

• To investigate the MKL1/miR34a/FOXP3 signaling axis in MGC803 gastric cancer cells.
• To elucidate the regulatory mechanisms of MKL1 on cell proliferation and gene expression in gastric cancer.

Main Methods:

• Overexpression of MKL1 in MGC803 cells.
• Knockdown of FOXP3 in MGC803 cells.
• Analysis of MKL1 binding to the CDK6 promoter.
• Investigation of miR34a's role in MKL1-mediated FOXP3 regulation.

Main Results:

• MKL1 overexpression significantly promoted MGC803 cell proliferation.
• MKL1 directly binds to the CDK6 promoter, increasing CDK6 expression.
• FOXP3 knockdown also enhanced MGC803 cell proliferation.
• MKL1 was found to inhibit FOXP3 expression through miR34a mediation.

Conclusions:

• The MKL1/miR34a/FOXP3 axis plays a crucial role in regulating gastric cancer cell proliferation.
• MKL1 promotes gastric cancer progression by upregulating CDK6 and downregulating FOXP3 via miR34a.
• This axis represents a potential therapeutic target for gastric cancer treatment.